Drugsrus Limited
Registered name: DRUGSRUS LIMITED
Part of 3VS UK Limited groupDrugsrus Limited made £55.6m revenue and £6.3m profit in the year to 31 Mar 2025.
Drugsrus Limited’s revenue fell 9% to £55.6m in the year to 31 Mar 2025, with £6.3m profit and 105 employees. The company is classified under “wholesale of pharmaceutical goods” and is based in Harrow; we hold 2 years of its filed accounts.
- Status
- Active
- Location
- Harrow, London
- Age
- 23 yrs · since 2003
- Type
- Private Limited Company
Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently.
Key figures
Badges are automated estimates derived from the filed figures — not statements of fact about the company.
Financial history
| Year to | 31 Mar 2024 | 31 Mar 2025 |
|---|---|---|
| Disclosure | Full P&L | Full P&L |
| Profit & loss | ||
| Revenue (turnover) | £61.3m | £55.6m |
| Cost of sales | £42m | £42.9m |
| Gross profit | £19.3m | £12.7m |
| Operating profit | £15.1m | £8.1m |
| Profit before tax | £15.1m | £8.4m |
| Profit after tax | £11.4m | £6.3m |
| Profit (best available) | £11.4m | £6.3m |
| Staff costs | £2.6m | £2.7m |
| Employees (average) | 102 | 105 |
| Ratios | ||
| Profit margin | 18.6% | 11.4% |
| Gross margin | 31.5% | 22.8% |
| Revenue per employee | £601k | £530k |
| Profit per employee | £111k | £60.2k |
| Cash conversion | −86.6% | −93.3% |
| Growth (year on year) | ||
| Revenue growth | — | ▼9.2% |
| Profit growth | — | ▼44.4% |
| Headcount growth | — | ▲2.9% |
| Balance sheet — indirect signals, not revenue | ||
| Cash at bank | £2.7m | £5.7m |
| Net assets | £20.9m | £27.2m |
| Fixed assets | £1.2m | £1.2m |
| Current assets | £29.4m | £36.4m |
| Debtors | £11.2m | £9m |
| Cash from operations | −£13.1m | −£7.6m |
| Source | FullAccounts · bulk data Mar 2026 | FullAccounts · bulk data Mar 2026 |
How the business works
- Profit margin
- 11.4%
- Profit ÷ revenue.
- Gross margin
- 22.8%
- Gross profit ÷ revenue. High for software and services.
- Revenue per employee
- £530k
- Revenue ÷ average employees.
- Profit per employee
- £60.2k
- Profit ÷ average employees.
- Cash conversion
- −93.3%
- Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
- Fixed assets ÷ revenue
- 2.1%
- Capital intensity. Low = capital-light, cheaper to start.
- Deferred income ÷ revenue
- —
- Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
- Debtors ÷ revenue
- 16.2%
- Money owed by customers. Low = customers pay quickly.
Balance-sheet signals
Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.
- Net assets
- ▲30%
- Now £27.2m
- Cash at bank
- ▲110%
- Now £5.7m
- Headcount
- ▲3%
- Now 105
- Deferred income
- —
- Now —
- Fixed assets
- ▲1%
- Now £1.2m
Group structure
Ownership chain
- 3VS UK Limitedultimate parent75–100%
- Drugsrus Limitedthis company
Bands show the share of ownership each company holds in the one below it.
Sister companies (1)
- Loxmeade LimitedFigures not disclosed
From the Persons with Significant Control register (corporate controllers only).
Similar profitable businesses
- Karo Healthcare UK LtdMaidenhead · Wholesale of pharmaceutical goods
- Revenue
- £54.4m
- Profit
- £1.8m
- Staff
- 78
- Milpharm LimitedUxbridge · Wholesale of pharmaceutical goods
- Revenue
- £57.9m
- Profit
- £2.5m
- Staff
- 61
- A1 Pharmaceuticals Public Limited CompanyRainham · Wholesale of pharmaceutical goods
- Revenue
- £60.1m
- Profit
- £2.7m
- Staff
- 52
- Respond Healthcare LimitedNewtownards · Wholesale of pharmaceutical goods
- Revenue
- £50.4m
- Profit
- £1.2m
- Staff
- 114
- Techdow Pharma England LimitedGuildford · Wholesale of pharmaceutical goods
- Revenue
- £48.8m
- Profit
- £871k
- Staff
- 12
- Waymade PLCBasildon · Wholesale of pharmaceutical goods
- Revenue
- £47.8m
- Profit
- £2.7m
- Staff
- 117
Sources
Latest figures from FullAccounts for the year to 31 Mar 2025 (profit £6.3m), from the Companies House accounts bulk data published Mar 2026. Spotted an error? Request a correction.
Updated from Companies House on 23 Oct 2026
Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.